Comparison

JND3229 European Partner

Item no. TMO-T15615-50mg
Manufacturer TargetMol
CASRN 2260886-64-2
Amount 50mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles O=C1N(C=2C(CN1C3=C(Cl)C=CC=C3)=CN=C(NC4=CC(C)=C(C=C4)N5CCN(C)CC5)N2)[C@H]6CC[C@H](NC(CC)=O)CC6
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 2260886-64-2
Available
Short Description
JND3229 is a reversible EGFRC797S inhibitor with IC50 values of 5.8, 6.8 and 30.5 nM for EGFRL858R/T790M/C797S, EGFRWT and EGFRL858R/T790M, respectively. JND3229 has good anti-proliferative activity and can effectively inhibit tumour growth in vivo. JND3229 can be used in cancer research, especially in non-small cell carcinoma.
Shipping
cool pack
Storage
-20°
Molecular Weight
617, 18
Pathway
JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Angiogenesis
Target
EGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?